Abstract:Fifteen compounds related to ameltolide with sodium channel inhibitory activity were subjected to a molecular docking study. The chemical structures of all compounds were built using the program HyperChem and conformational studies were performed with a semiempirical method followed by the PM3 method. A docking study was performed using the program AutoDock on all the compounds. To confirm the binding mode of inhibitors, molecular dynamics simulations were performed using GROMACS 4.5.5, based upon the docked conformation of ameltolide. The docking analyses indicated that these compounds interacted mainly with residues II-S6 and III-S6 of NaV1.2 by making hydrogen bonds and ( π − π) interactions with domains I, III, and IV in the channel's inner pore. Our docking study reveals that amide linker plays a major role in the drug-receptor interaction. The results of molecular dynamic simulations confirmed the binding mode of ligands, the accuracy of docking, and the reliability of active conformations obtained by AutoDock.
Introduction
Epilepsy is a serious neurological disorder that 1% of the world's population is affected by 1,2 and among them 30% of sufferers have uncontrolled seizures. Most antiepileptic drugs are associated with adverse effects, such as sedation, ataxia, and weight loss (e.g., topiramate) or weight gain (e.g., valproate, tiagabine, and vigabatrin). Rare adverse effects can be life threatening, such as rashes leading to Stevens-Johnson syndrome (e.g., lamotrigine) or aplastic anemia (e.g., felbamate). 2, 3 Therefore, the development of safer and more effective new antiepileptic drugs (AEDs) is necessary.
1−5
Sodium channels are one of the best targets in the treatment of epilepsy. Neuronal voltage-gated sodium channels (NVSCs) play an important role in the production and spread of action potentials in neurons and other excitable cells. Therefore, NVSC blocking agents constitute a clinically important class of drugs used in the treatment of neurological disorders. NVSCs usually include an alpha subunit that organizes the ion conduction pore and one to two beta subunits. 6 The alpha subunit has four repeat domains, marked I to IV, each containing six membrane-spanning regions, marked S1 to S6. The family of sodium channels has nine known members. The proteins of these channels are labeled Nav1.1 to Nav1.9.
7,8
Docking studies are used at different stages in drug discovery such as in prediction of the docked structure of a ligand-receptor complex and also to rank ligand molecules based upon their binding energy. Docking protocols aid in elucidation of the most energetically favorable binding pose of a ligand to its receptor.
Our work is based on one of the potent AEDs, ameltolide, which previously was investigated by Eli Lilly, originally emerging from the laboratories of Clark and coworkers.
9−15 These groups of investigators isolated the promising 4-aminobenzamide pharmacophore, which subsequently led to the fruitful design of several new and potent anticonvulsant compounds. In this paper, we report the molecular modeling and drug-receptor interaction profile of 15 compounds structurally related to ameltolide (Figure 1) 
Results and discussion
Flexible docking of all data sets used for the computational study 19 was carried out on the active site of the open pore of the sodium channel. The lowest energy and maximum number of conformations per cluster were set as the criteria to predict the binding modes of the compounds. Our docking results (Figure 2a ) indicate that the CO-NH moiety of ameltolide and its benzanilides derivatives bind to the sodium channel in the trans form and this form is stable in the molecular dynamic simulation (Figure 2b ). Based on the procedure explained in the experimental section, the binding affinity of the docked molecules was evaluated by binding energy, docked energy, calculated inhibition constants (calc. K i ) , and hydrogen bonds in addition to the hydrophobic interactions at the channel pocket. The poses of all compounds are presented in the Table. The predicted binding and docked energies are the sum of the intermolecular energy and the torsional free-energy penalty, and the docking ligand's internal energy, respectively, and the inhibition constant (K i ) is calculated in AutoDock4 as follows:
where ∆ G is the docking energy, Rcal is 1.98719, and TK is 298. interaction with domains I, III, and IV in the inner pore of the channel (Figure 10 ). This docking analysis reveals that amide linker plays a major role in the drug-receptor interaction because replacing it by thioamide linker in compound VII results in significantly increasing the binding energy and K i , which agree with the biological activity of these derivatives. 16 Docking and pharmacological data of the subgroup of ameltolide and phthalimide derivatives confirm that there is no significant reduction in the anticonvulsant effect between the compounds with opening and closing pyrrolidine rings. Based on the pharmacological study, ameltolide (compound II) appears to be as potent as phenytoin in interacting with the Na channel. The phthalimide (compound X) and nitro counterparts of ameltolide (compound I) are several times more potent than ameltolide and phenytoin in binding tests and oral (maximal electroshock seizure) MES tests in rats, which agree with the docking study of these compounds. 
Molecular dynamics simulation
To confirm the binding profile of ligands and to give an overall impression about the ameltolide derivatives, ameltolide was subjected to 10 ns molecular dynamics (MD) simulations. The equilibration was monitored and confirmed by examining the stability of the temperature, pressure, density, and potential energy of the system as well as the root mean squared deviations (RMSDs) of the backbone atoms. The average backbone RMSD of receptor was 0.6974 ± 0.0010Å with respect to the starting structure and the potential energy equilibrated about an average of -556,254 ± 777.026 kJ/mol. Average temperature, pressure, and density were 300.001 T between NH 2 of ameltolide and the oxygen atom in residue Asn88. Figures 2a and 2b show the drug-receptor interactions before and after 10 ns MD simulation; in both of them there is an efficient hydrogen bond between Asn88 and drug. In analyzing the drug-enzyme complex, our observation reveals that the complex was stable to the simulation conditions and ameltolide remained in the active site pocket (Figures 2a and 2b) . The results of MD simulations confirmed the binding mode of ligands, the accuracy of docking, and the reliability of active conformations obtained by AutoDock.
The docking analyses indicated that these compounds interacted mainly with residues II-S6 and III-S6 of NaV1.2 by making hydrogen bonds and (π -π) interactions with domains I, III, and IV in the channel's inner pore. Our docking analysis reveals that amide linker plays a major role in drug-receptor interactions. It is noteworthy that the MD simulation study corroborates the accuracy of the results of docking analysis.
Experimental

Molecular modeling
The molecular modeling and docking procedures were based on our previous articles.
25−28 X-ray crystallography revealed that ameltolide exists in the trans configuration but using molecular modeling it was suggested that the CO-NH moiety of ameltolide and its derivatives bind to their biological target in their cis configuration.
29
Because of the greater reliability of the crystallographic results and small energy difference between the cis and trans forms (3 kcal/mol), 29 in the flexible docking study the trans form was considered and also the amide bond was considered as a rotatable bond to create both the cis and trans forms in docking calculations. The chemical structures of inhibitors ( Figure 1 ) were constructed using HyperChem software (version 7, Hypercube Inc.). Conformational analysis of the favorite compounds was executed through semiempirical molecular orbital calculations (PM 3 ) by utilizing the software HyperChem.
Total energy gradient was assessed using the Polak-Ribiere (conjugate gradient) algorithm as a root mean square (RMS) value, until the RMS gradient was 0.01 kcal mol −1 . The gradient (G) is the rate of change (first derivative) of total energy (TE) with regard to movement of each atom in the x, y, and z directions for atoms from 1 to n. HyperChem reports this value for geometry optimization and single point calculations. An RMS gradient of zero means that the structure is at a local minimum or saddle point in the potential energy surface, not necessarily at the structure and state of the lowest energy (global minimum).
Energy minimization alters molecular geometry to lower the energy of the system and yields a more stable conformation. The generation of new starting conformations for energy minimization uses random variation of dihedral angles. Rotation is used for acyclic bond dihedral angles. As the minimization progresses, it searches for a molecular structure in which the energy does not change with miniscule changes in geometry. This means that the derivative of the energy with respect to all Cartesian coordinates, called the gradient, is near zero. If small changes in geometric parameters raise the energy of the molecule, the conformation is relatively stable, and this is referred to as a minimum. If the energy lowers by small changes in one or more dimensions, but not in all dimensions, it is a saddle point. A molecular system can have many minima. The one with the lowest energy is called the global minimum and the rest are referred to as local minima. Among all energy minima conformers, the global minima of compounds were applied in docking calculations and the resulting geometry was transferred into AutoDock (version 4.2), which was developed by Arthur J Olson's Chemometrics Group.
19
The structure of the docked conformer of compound II is shown in Figure 1. 
Docking
Docking calculations were executed using AutoDock (version 4.2). A model of the open pore of the Na channel was utilized as a receptor (Figures 13a and 13b) . This open pore model was developed based on a homology model of the crystal structures of the K channel. 17, 18 The model constructed by homology with K channel structures was advisedly successful in accounting for inner pore residue interactions with local anesthetics and anticonvulsant drugs like phenytoin. The desired compounds were docked in to the active site as well as phenytoin, which was acting as our reference drug for validation of our procedure.
Docking was done using AutoDock 4.2; in order to assign the perfect grid of each ligand, grid box values were obtained by trial and error and from previous research. 20 −23 Grid maps with 60 × 60 × 60 points were made and the grid point spacing was 0.375Å. 24 The Lamarckian genetic algorithm (LGA), considered one of the best docking methods available in AutoDock, was adopted to perform the molecular docking studies. The parameters for LGA were defined as follows: a maximum number of 250,000 energy evaluations, a maximum number of generations of 27,000, and mutation and crossover rates of 0.02 and 0.8, respectively. Pseudo-Solis and Wets parameters were used for the local search, and 300 iterations of the Solis and Wets local search were imposed. Both AutoGrid and AutoDock computations were performed on Cygwin and 100 independent docking runs were performed for each phthalimide. Final docked conformations were clustered using a tolerance of 1 A RMSD and the docking log (dlg) files were analyzed using AutoDock Tools, the graphical user interface of AutoDock. The docked conformations of each ligand were ranked into clusters based on the binding energy and the top ranked conformations were visually analyzed. Hydrogen bonding and hydrophobic interactions between docked potent agents and macromolecules were analyzed using AutoDock Tools (version 1.50).
Molecular dynamics simulation studies
To confirm the binding mode of inhibitors, the MD simulations were performed using GROMACS 4.5.5 30, 31 based on the docked conformation of ameltolide and whole protein. A united-atom GROMOS96 43A1 force field was used for protein parameters and using the PRODRG server, and a GROMOS87/GROMOS96 force field was used to generate a starting topology for ameltolide. One Na + ion was added to neutralize the system, and then solvated in a cubic box of spc water molecules.
Before the MD simulation, the complexes were subjected to 50,000 steps of energy minimization to relieve any geometric strain and close intermolecular contacts. To begin real dynamics, the solvent and ions were equilibrated around the protein. Equilibration was conducted in two phases: NVT and NPT. In the first phase, with a weak constraint to the system (10 kcal/mol), the system was conducted under an NVT ensemble (constant number of particles, volume, and temperature) and was gradually heated from 0 to 300 K in 100 ps and then equilibrated for 100 ps at 300 K. In the second phase of equilibration, the system was conducted under an NPT ensemble (constant number of particles, pressure, and temperature) and equilibrated for 100 ps at 300 K. Then a 10 ns MD simulation was performed using the periodic boundary conditions, with constant temperature and pressure (1 bar at 300 K). The output trajectories were recorded every 2 ps for the purpose of subsequent analysis. The equilibration was monitored by examining the stability of the temperature, pressure, potential energy, and density of the system as well as the RMSD of the backbone atoms. 32, 33 
